Back
 IJCM  Vol.7 No.10 , October 2016
Fasting for Laboratory Tests Poses a High Risk of Hypoglycemia in Patients with Diabetes: A Pilot Prevalence Study in Clinical Practice
Abstract: Objective: Fasting for lipid profiles is a deeply-rooted tradition that is being revisited. In patients with diabetes, such fasting poses a risk of hypoglycemia, as observed in recent studies and case reports. This iatrogenic, overlooked, form of hypoglycemia has been referred to as Fasting-Evoked En-route Hypoglycemia in Diabetes (FEEHD). The objective of the study is to determine the prevalence of FEEHD in clinical practice. Methods: A two-page survey was administered to adults with diabetes on anti-diabetic medication(s). Patients were asked if they recalled having experienced hypoglycemia while fasting for laboratory tests (FEEHD) during the preceding 12 months. Results: Of 168 patients enrolled, 166 completed the survey, with a mean age of 55.3 (SD: 15.4) years. Seventy-nine (47.6%) were females. Of these 166 patients, 119 (71 %) had type 2 diabetes. Forty-five patients (27.1%) reported having experienced one or more FEEHD events. Notably, only 31.1% of the patients who experienced a FEEHD event informed their provider of the event, and only 40% of FEEHD events reportedly resulted in any subsequent provider-made medication change(s) to prevent future events. Conclusions: This is the first study of FEEHD prevalence in clinical practice, the results of which serve to increase awareness amongst clinicians about the occurrence of FEEHD. We believe that FEEHD appears to be overlooked by clinicians. The prevalence of FEEHD in clinical practice is strikingly high (27.1%). More concerning is the significant underreporting of FEEHD events by patients to their clinicians (31%). We hope this study will trigger further investigation to confirm these preliminary findings and modify practice guidelines.
Cite this paper: Aldasouqi, S. , Corser, W. , S. Abela, G. , Mora, S. , Shahar, K. , Krishnan, P. , Bhatti, F. , Hsu, A. and Gruenebaum, D. (2016) Fasting for Laboratory Tests Poses a High Risk of Hypoglycemia in Patients with Diabetes: A Pilot Prevalence Study in Clinical Practice. International Journal of Clinical Medicine, 7, 653-667. doi: 10.4236/ijcm.2016.710071.
References

[1]   The American Diabetes Association (2016) Standards of Medical Care in Diabetes—2016. Diabetes Care, 38, S1-S112.

[2]   National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) (2002) Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation, 106, 3143-3421.

[3]   Grunberger, G. (2011) Do We Need a Fasting Lipid Profile to Assess Cardiovascular Risk? Journal of Diabetes, 3, 172-173.
http://dx.doi.org/10.1111/j.1753-0407.2011.00141.x

[4]   Gaziano, J.M. (2012) Should We Fast before We Measure Our Lipids? Archives of Internal Medicine, 172, 1705-1706.
http://dx.doi.org/10.1001/jamainternmed.2013.1771

[5]   Khera, A. and Mora, S. (2012) Fasting for Lipid Testing: Is It Worth the Trouble? Archives of Internal Medicine, 172, 1710-1712.
http://dx.doi.org/10.1001/2013.jamainternmed.263

[6]   Sidhu, D. and Naugler, C. (2012) Fasting Time and Lipid Levels in a Community-Based Population: A Cross-Sectional Study. Archives of Internal Medicine, 172, 1707-1710.
http://dx.doi.org/10.1001/archinternmed.2012.3708

[7]   Aldasouqi, S.A. and Grunberger, G. (2013) Is It Time to Eliminate the Need for Overnight Fasting for Lipid Tests in Patients with Diabetes? JAMA Internal Medicine, 27, 936-937.
http://dx.doi.org/10.1001/jamainternmed.2013.398

[8]   Doran, B., Guo, Y., Xu, J., et al. (2014) Prognostic Value of Fasting versus Nonfasting Low-Density Lipoprotein Cholesterol Levels on Long-Term Mortality: Insight from the National Health and Nutrition Survey III (NHANES-III). Circulation, 130, 546-553.
http://dx.doi.org/10.1161/CIRCULATIONAHA.114.010001

[9]   Aldasouqi, S. and Abela, G. (2015) Letter by Aldasouqi and Abela Regarding Article, “Prognostic Value of Fasting Versus Nonfasting Low-Density Lipoprotein Cholesterol Levels on Long-Term Mortality: Insight From the National Health and Nutrition Survey III (NHANES-III)”. Circulation, 131, e471.
http://dx.doi.org/10.1161/CIRCULATIONAHA.114.012564

[10]   Aldasouqi, S., Sheikh, A., Klosterman, P., et al. (2011) Hypoglycemia in Patients with Diabetes on Antidiabetic Medications Who Fast for Laboratory Tests. Diabetes Care, 34, e52.
http://dx.doi.org/10.2337/dc10-2402

[11]   Aldasouqi, S., Sheikh, A., Klosterman, P., et al. (2013) Hypoglycemia in Patients with Diabetes Who Fast for Lab Tests: A Follow up of the Cape Girardeau Hypoglycemia Prevention Program. Postgraduate Medical Journal, 125, 136-143.
http://dx.doi.org/10.3810/pgm.2013.01.2629

[12]   Aldasouqi, S., Gossain, V., Hebdon, M., et al. (2012) Causes of Fasting-Evoked Hypoglycemia in Diabetes (FEEHD): A Case Series. International Journal of Clinical Medicine, 3, 751-757.
http://dx.doi.org/10.4236/ijcm.2012.37A132

[13]   Aldasouqi, S. and Grunberger, G. (2014) The Traditions and Risks of Fasting for Lipid Profiles in Patients with Diabetes. Postgraduate Medicine Journal, 126, 98-107.
http://dx.doi.org/10.3810/pgm.2014.11.2837

[14]   Fowler, M.J. (2011) The Diabetes Treatment Trap: Hypoglycemia. Clinical Diabetes, 29, 36-39.
http://dx.doi.org/10.2337/diaclin.29.1.36

[15]   Workshop on Hypoglycemia, American Diabetes Association (2005) Defining and Reporting Hypoglycemia in Diabetes: A Report from the American Diabetes Association Workgroup on Hypoglycemia. Diabetes Care, 28, 1245-1249.
http://dx.doi.org/10.2337/diacare.28.5.1245

[16]   Pedersen-Bjergaard, U., Færch, L., Allingbjerg, M.L., Agesen, R. and Thorsteinsson, B. (2015) The Influence of New European Union Driver’s License Legislation on Reporting of Severe Hypoglycemia by Patients with Type 1 Diabetes. Diabetes Care, 38, 29-33.
http://dx.doi.org/10.2337/dc14-1417

[17]   Wiwanitkit, V. (2004) Case of Sudden Death in Venipuncture Clinic. Phlebotomy, 19, 193.
http://dx.doi.org/10.1258/0268355042554993

[18]   The American Diabetes Association (2012) Standards of Medical Care in Diabetes—2012. Diabetes Care, 35, S11-S63.
http://dx.doi.org/10.2337/dc12-s011

[19]   The American Diabetes Association (2011) Standards of Medical Care in Diabetes—2011. Diabetes Care, 34, S11-S61.
http://dx.doi.org/10.2337/dc11-s011

[20]   Foster M. (2011) Survey Reveals Low Hypoglycemia Awareness among Patients with Diabetes. Endocrine Today.
http://www.healio.com/endocrinology/diabetes/news/print/endocrine-today/%
7Be3d5b9ab-65d9-4796-890b-3b69df497be4%7D/survey-reveals-low-
hypoglycemia-awareness-among-patients-with-diabetes


[21]   Skarulis, M.C. and Hirshberg, B. (2004) Hypoglycemia in the Adult. In: LeRoith, D., Taylor, S.I. and Olefsky, J.M., Eds., Diabetes Mellitus: A Fundamental and Clinical Text, 3rd Edition, Lippincott Williams & Wilkins, Philadelphia, 1427-1438.

[22]   Frier, B.M. (2000) Hypoglycemia and Driving Performance. Diabetes Care, 23, 148-149.
http://dx.doi.org/10.2337/diacare.23.2.148

[23]   Cox, D.J., Gonder-Frederick, L.A., Kovatchev, B.P., Julian, D.M. and Clarke, W.L. (2000) Progressive Hypoglycemia’s Impact on Driving Simulation Performance: Occurrence, Awareness and Correction. Diabetes Care, 23, 163-170.
http://dx.doi.org/10.2337/diacare.23.2.163

[24]   The American Diabetes Association (2016) 8. Cardiovascular Disease and Risk Management. Diabetes Care, 39, S60-S71.
http://dx.doi.org/10.2337/dc16-S011

[25]   Tan, S.Y. (2012) Law and Medicine: Physician Liability in Driving Accidents. Clinical Endocrinology News.
http://www.clinicalendocrinologynews.com/views/law-medicine/blog/physician-liability-in
-driving-accidents/f94a86515778e327464be37b744698dd.html


[26]   Bansal, S., Buring, J.E., Rifai, N., et al. (2007) Fasting Compared with Nonfasting Triglycerides and Risk of Cardiovascular Events in Women. JAMA, 298, 309-316.
http://dx.doi.org/10.1001/jama.298.3.309

[27]   Langsted, A., Freiberg, J.J., Tybjaerg-Hansen, A., Schnohr, P., Jensen, G.B. and Nordestgaard, B.G. (2011) Nonfasting Cholesterol and Triglycerides and Association with Risk of Myocardial Infarction and Total Mortality: The Copenhagen City Heart Study with 31 Years of Follow-Up. Journal of Internal Medicine, 270, 65-75.
http://dx.doi.org/10.1111/j.1365-2796.2010.02333.x

[28]   Downs, J.R. and O’Maley, P.G. (2015) Management of Dyslipidemia for Cardiovascular Risk Reduction: Synopsis of the 2014 US Department of Veterans Affairs and US Department of Defense Clinical Practice Guideline. Annals of Internal Medicine, 163, 291-297.
http://dx.doi.org/10.7326/M15-0840

[29]   Nordestgaard, B.G. and Varbo, A. (2014) Triglycerides and Cardiovascular Disease. Lancet, 384, 626-635.
http://dx.doi.org/10.1016/S0140-6736(14)61177-6

[30]   Langsted, A. and Nordestgaard, B. (2015) Nonfasting Lipid Profiles: The Way of the Future. Clinical Chemistry, 61, 1123-1125.
http://dx.doi.org/10.1373/clinchem.2015.243139

[31]   Rifai, N., Young, I., Nordestgaard, B., Wierzbicki, A., et al. (2016) Nonfasting Sample for the Determination of Routine Lipid Profile: Is It an Idea Whose Time Has Come? Clinical Chemistry, 62, 428-435.
http://dx.doi.org/10.1373/clinchem.2015.247866

[32]   Mora, S. (2016) Nonfasting for Routine Lipid Testing: From Evidence to Action. JAMA Internal Medicine, 176, 1005-1006.
http://dx.doi.org/10.1001/jamainternmed.2016.1979

[33]   Nordestgaard, B.G., Langsted, A., Mora, S., et al. (2016) Fasting Is Not Routinely Required for Determination of a Lipid Profile: Clinical and Laboratory Implications Including Flagging at Desirable Concentration Cut-Points—A Joint Consensus Statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine. European Heart Journal, 37, 1944-1958.
http://dx.doi.org/10.1093/eurheartj/ehw152

 
 
Top